Correction to: Leukemia ; https://doi.org/10.1038/leu.2017.173; published online 2 June 2017

Following the publication of this article, the authors noted that the pomalidomide dose for the additional SC cohort in Fig.1 was incorrectly listed. The correct dose for pomalidomide in the additional SC cohort should be the maximum tolerated dose of 4 mg/day, not 2 mg/day as listed in the original Fig. 1. The authors apologize for any inconvenience caused.